01 1Novartis Pharmaceuticals Canada Inc.
02 10Novo Nordisk Canada Inc.
03 3Sanofi-Aventis Canada Inc.
01 112258097
02 32896375
01 6INSULIN ASPART
02 8Insulin Aspart
01 8Liquid
02 6SOLUTION
01 112017-06-19
02 32034-02-03
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Brand Name : FIASP
Patent Number : 2258097
Filing Date : 1997-06-19
Strength per Unit : 100 units pr. mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Brand Name : NOVOMIX 30
Patent Number : 2258097
Filing Date : 1997-06-19
Strength per Unit : 100 U / ml
Dosage Form : Liquid
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Brand Name : NOVOMIX 50
Patent Number : 2258097
Filing Date : 1997-06-19
Strength per Unit : 100 U / ml
Dosage Form : Liquid
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Brand Name : NOVOMIX 50
Patent Number : 2258097
Filing Date : 1997-06-19
Strength per Unit : 100 U / ml
Dosage Form : Liquid
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Brand Name : NOVOMIX 70
Patent Number : 2258097
Filing Date : 1997-06-19
Strength per Unit : 100 U / ml
Dosage Form : Liquid
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Brand Name : NOVOMIX 70
Patent Number : 2258097
Filing Date : 1997-06-19
Strength per Unit : 100 U / ml
Dosage Form : Liquid
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Brand Name : NOVORAPID
Patent Number : 2258097
Filing Date : 1997-06-19
Strength per Unit : 100 U/ml
Dosage Form : Liquid
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Brand Name : NOVORAPID
Patent Number : 2258097
Filing Date : 1997-06-19
Strength per Unit : 100 U/ml
Dosage Form : Liquid
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Brand Name : NOVOMIX 30
Patent Number : 2258097
Filing Date : 1997-06-19
Strength per Unit : 100 U / ml
Dosage Form : Liquid
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Brand Name : FIASP
Patent Number : 2258097
Filing Date : 1997-06-19
Strength per Unit : 100 units pr. mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
